Objective
Glucagon is secreted by pancreatic α-cells in response to hypoglycemia and its hyperglycemic effect helps to restore normal blood glucose. Insulin and somatostatin (SST) secretions from β- and δ-cells, respectively, are stimulated by glucose by mechanisms involving an inhibition of their ATP-sensitive K
+
(K
ATP
) channels, leading to an increase in [Ca
2+
]
c
that triggers exocytosis. Drugs that close K
ATP
channels, such as sulfonylureas, are used to stimulate insulin release in type 2 diabetic patients. α-cells also express K
ATP
channels. However, the mechanisms by which sulfonylureas control glucagon secretion are still largely debated and were addressed in the present study. In particular, we studied the effects of K
ATP
channel blockers on α-cell [Ca
2+
]
c
and glucagon secretion in the presence of a low (1 mM) or a high (15 mM) glucose concentration and evaluated the role of SST in these effects.
Methods
Using a transgenic mouse model expressing the Ca
2+
-sensitive fluorescent protein, GCaMP6f, specifically in α-cells, we measured [Ca
2+
]
c
in α-cells either dispersed or within whole islets (by confocal microscopy). By measuring [Ca
2+
]
c
in α-cells within islets and glucagon secretion using the same perifusion protocols, we tested whether glucagon secretion correlated with changes in [Ca
2+
]
c
in response to sulfonylureas. We studied the role of SST in the effects of sulfonylureas using multiple approaches including genetic ablation of SST, or application of SST-14 and SST receptor antagonists.
Results
Application of the sulfonylureas, tolbutamide, or gliclazide, to a medium containing 1 mM or 15 mM glucose increased [Ca
2+
]
c
in α-cells by a direct effect as in β-cells. At low glucose, sulfonylureas inhibited glucagon secretion of islets despite the rise in α-cell [Ca
2+
]
c
that they triggered. This glucagonostatic effect was indirect and attributed to SST because, in the islets of SST-knockout mice, sulfonylureas induced a stimulation of glucagon secretion which correlated with an increase in α-cell [Ca
2+
]
c
. Experiments with exogenous SST-14 and SST receptor antagonists indicated that the glucagonostatic effect of sulfonylureas mainly resulted from an inhibition of the efficacy of cytosolic Ca
2+
on exocytosis. Although SST-14 was also able to inhibit glucagon secretion by decreasing α-cell [Ca
...